ALTTOAdjuvant Lapatinib and/or Trastuzumab Treatment Optimisation
References in periodicals archive ?
This combination also has exciting potential as treatment for early stage breast cancer, a hypothesis that is being evaluated now in the global ALTTO trial.
About 8,000 people in 50 countries will be given either one of the drugs or a combination of both in a trial dubbed ALTTO.
ALTTO will examine how patients perform on the drugs for a year, after first having their tumors surgically removed.